Position in ALVO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$27,080
-$4,578 QoQ
Shares Held
7,339
-20.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 72 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. ALVO ranks #49 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
262,200 | $142,067,824 | |
| 2 | ZTS |
Zoetis Inc.
|
1,265,210 | $90,917,989 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,527,031 | $85,615,809 | |
| 4 | VTRS |
Viatris Inc
|
4,360,444 | $69,243,850 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
179,076 | $30,181,467 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
643,006 | $26,382,535 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
189,692 | $21,044,429 | |
| 8 | HLN |
Haleon plc
|
1,507,538 | $14,065,329 |
All Filings in ALVO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,080 | 7,339 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $31,658 | 9,230 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $73,712 | 14,369 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $49,295 | 6,019 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $46,375 | 5,085 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $42,422 | 4,387 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||